News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Axsome Therapeutics Receives FDA Approval for SYMBRAVO® to Treat Acute Migraine in Adults
Friday, January 31, 2025Axsome Therapeutics Inca biopharmaceutical company focused on central nervous system CNS disorders has received approval from the US Food and Drug Administration FDA for SYMBRAVO meloxicam and rizatriptan The treatment is intended for acute migraine...
Chugai and GSK Partner on Anti-Dengue Virus Antibody AID351
Friday, January 31, 2025Chugai Pharmaceutical Co Ltdhas entered into a collaboration agreement with GSKs Global Health Unit GSK GH to advance the development of an antidengue virus antibody Under this agreement GSK GH will assess potential funding and carry out activities t...
Siolta Therapeutics and Cowellnex Enter Joint Research Agreement
Thursday, January 30, 2025Siolta Therapeutics a leader in the development of live biotherapeutic products LBPs and Cowellnex Co Ltd a Kirin and Kyowa Kirin joint investment have signed a preclinical joint research agreement to develop an LBP aimed at the prevention of necroti...
Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe
Thursday, January 30, 2025Greenwich LifeSciences Inc a clinicalstage biopharmaceutical company focused on its Phase III clinical trial FLAMINGO which is evaluating GLSI an immunotherapy to prevent breast cancer recurrences today provided the following update on the expansion...
Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner
Wednesday, January 29, 2025Argonaut Manufacturing Services a leading contract development and manufacturing organization serving the biopharma and life sciences industries and Akoya Biosciences Inc The Spatial Biology Company announced today that Argonaut will act as the manuf...
Humacyte and Pluristyx Announce Gene Editing Partnership to Support BioVascular Pancreas (BVP™) Development Using iPSCs
Wednesday, January 29, 2025Humacyte Inc a commercialstage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale and Pluristyx Inc today announced an expanded partnership Pluristyx makes and sells PluriBank iPSC lines a...
Apellis Gains Approval for SYFOVRE® (pegcetacoplan) in Australia to Treat Geographic Atrophy (GA)
Tuesday, January 28, 2025Apellis Pharmaceuticals Inchas announced that the Therapeutic Goods Administration TGA in Australia has approved SYFOVRE pegcetacoplan for the treatment of geographic atrophy GA secondary to agerelated macular degeneration AMD
Corstasis Therapeutics Inc. Announces FDA Approval of New Drug Application for Bumetanide Nasal Spray
Monday, January 27, 2025Corstasis Therapeutics Inc a clinicalstage MedTech pharmaceutical company focused on developing practical treatments for fluid overload has announced that the US Food and Drug Administration FDA has accepted the New Drug Application NDA for its innov...
MilliporeSigma Collaborates with Opentrons Labworks, Inc. to Support the Laboratory of the Future
Friday, January 24, 2025MilliporeSigma the Life Science business of Merck KGaA Darmstadt Germany in the US and Canada has signed a multiyear agreement with Opentrons Labworks Inc a leader in laboratory automation and robotics to automate assay kits using a customised Opentr...
Zai Lab Granted Orphan Drug Status by U.S. FDA for ZL-1310 (DLL3 ADC) in Treating Small Cell Lung Cancer (SCLC)
Thursday, January 23, 2025Zai Lab Limitedannounced that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD to ZL a novel and potentially firstinclass DLL antibodydrug conjugate ADC for treating small cell lung cancer SCLC
